SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Akinci E, Yüzbaşıoğlu Y, Coskun F. Am. J. Emerg. Med. 2011; 29(9): 1235.e5-6.

Copyright

(Copyright © 2011, Elsevier Publishing)

DOI

10.1016/j.ajem.2010.08.027

PMID

20971596

Abstract

Mexiletine is a class IB antiarrhythmic agent. Although it is primarily used in treating ventricular arrhythmias, recent indications for use of mexiletine include chronic and neuropathic pains. At high doses, mexiletine causes drowsiness, confusion, nausea, hypotension, sinus bradycardia, paresthesia, seizures, bundle branch block, atrioventricular heart block, ventricular arrhythmias, asystole, cardiovascular collapse, and coma. A 23-year-old male patient presented to the emergency department with intentional ingestion of high-dose mexiletine. Despite decontamination and supportive treatment, his vitals deteriorated during the observation period; and he developed stupor and dysarthria. Patient then underwent hemodialysis. His vital signs and overall condition improved rapidly following hemodialysis treatment. In this case report, we aimed to emphasize hemodialysis as a useful alternative therapy for severe mexiletine intoxications.


Language: en

Keywords

Humans; Male; Young Adult; Drug Overdose; Suicide, Attempted; Renal Dialysis; Anti-Arrhythmia Agents; Mexiletine

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print